metricas
covid
Buscar en
Gastroenterología y Hepatología
Toda la web
Inicio Gastroenterología y Hepatología Dilatación de la papila de Vater en el tratamiento de la coledocolitiasis en pa...
Journal Information
Vol. 27. Issue 1.
Pages 6-10 (January 2004)
Share
Share
Download PDF
More article options
Vol. 27. Issue 1.
Pages 6-10 (January 2004)
Full text access
Dilatación de la papila de Vater en el tratamiento de la coledocolitiasis en pacientes seleccionados
Dilatation Of The Papilla Of Vater In The Treatment Of Choledocholithiasis In Selected Patients
Visits
4994
J. Espinel
Corresponding author
jespinel@telefonica.net

Correspondencia: Dr. J. Espinel Diez. Brianda de Olivera, 13, Esc.2, 3.o B. 24005 León. España.
, F. Muñoz, S. Vivas, A. Domínguez, P. Linares, F. Jorquera, A. Herrera, J.L. Olcoz
Sección de Aparato Digestivo. Hospital de León. León. España
This item has received
Article information
Objetivo

: Analizar prospectivamente los resultados obtenidos mediante dilatación neumática papilar (DNP) en el tratamiento de coledocolitiasis, en pacientes con riesgo de complicaciones si se realizara esfinterotomía endoscópica (EE).

Pacientes Y Metodo

: Se incluyen 33 pacientes entre enero de 2001 y junio de 2003 (edad media 76,2 años). Los criterios de DNP fueron: coledocolitiasis ≤ 10 mm en pacientes con diverticulos peripapilares, alteraciones hemostaticas, Billroth II o preservacion del esfinter de Oddi. La sedacion se realizo por anestesista en el 79% de los pacientes. La DNP se efectuo con un cateter balon dilatador de 8 o 10 mm de diametro, durante 2 min. Se valoro la eficacia, la duracion del procedimiento, las complicaciones al dia 30 y el grado de satisfaccion de los pacientes.

Resultados

: Se consiguio la extraccion de los calculos en todos ellos (100%). La duracion media fue de 26 min. Dos pacientes presentaron pancreatitis leve (6%). Hubo elevacion de la amilasa serica en 16 pacientes (48%): ≥ 3 veces (hiperamilasemia post-DNP) en 11 (33%). La prueba fue nada molesta en 25/26 (96%) pacientes sedados por anestesista frente a 2/5 (40%) sedados por endoscopista.

Conclusiones

: La DNP es una opción terapéutica eficaz y sencilla en el tratamiento de coledocolitiasis de pequeno tamano (. 10 mm), en situaciones especiales de riesgo. La duración de la colangiopancreatografía retrógrada endoscópica (CPRE) no supone un tiempo prolongado. Las complicaciones son infrecuentes (6%) y leves. La hiperamilasemia post-DNP es frecuente y generalmente sin trascendencia clinica. La sedación por un anestesista mejora la satisfaccion del paciente.

Objective

: To prospectively analyze the results obtained with papillary balloon dilatation (PBD) in the treatment of common bile duct stones in patients at risk of complications if endoscopic sphincterotomy (ES) were performed.

Patients and Method

: Thirty-three patients were included between January 2001 and June 2003 (mean age 76.2 years). The criteria for PBD were: choledocholithiasis ≤ 10 mm in patients with peripapillary diverticula, hemostatic alterations, Billroth-II, and preservation of Oddi's sphincter. In 79% of the patients sedation was performed by an anesthetist. PBD was performed with a balloon catheter dilator with a diameter of 8 or 10 mm for 2 minutes. The efficacy and duration of the procedure as well as complications at 30 days and patient satisfaction were evaluated.

Results

: Stone extraction was achieved in all patients (100%). The mean duration of the procedure was 26 minutes. Two patients (6%) presented mild pancreatitis. Serum amylase was elevated in 16 patients (48%): ≥ 3 times (post-PBD hyperamylasemia) in 11 (33%). The procedure caused no discomfort in 25/26 (96%) of the patients sedated by an anesthetist vs 2/5 patients (49%) who underwent endoscopic sedation.

Conclusions

: PBD is an effective and simple therapeutic option in the treatment of small common bile duct stones (≤ 10 mm) and in patients at high risk. The duration of endoscopic retrograde cholangiopancreatography is not prolonged. Complications are infrequent (6%) and mild. Post- PBD hyperamylasemia is frequent and generally without clinical importance. Sedation by an anesthetist improves patient satisfaction.

Full text is only aviable in PDF
Biblografía
[1.]
G.R. May, P.B. Cotton, S.E.J. Edmunds, W. Chong.
Removal of stones from the bile duct at ERCP winthout sphincterotomy.
Gastrointest Endosc, 39 (1993), pp. 749-754
[2.]
P. MacMathuna, P. White, E. Clarke, J. Lennon, J. Crowe.
Endoscopic sphincteroplasty: a novel and safe alternative to papillotomy in the management of bile duct stones.
Gut, 35 (1994), pp. 127-129
[3.]
P. MacMathuna, P. White, E. Clarke, R. Merriman, J. Lennon, J. Crowe.
Endoscopic balloon sphincteroplasty (papillary dilation) for bile duct stones: efficacy, safety and follow-up in 100 patients.
Gastrointest Endosc, 42 (1995), pp. 468-474
[4.]
A. Minami, T. Nakatsu, N. Uchida, S. Hirabayashi, H. Fukuma, S.A. Morshed, et al.
Papillary dilation vs sphincterotomy in endoscopic removal of bile duct stones. A randomized trial with manometric function.
Dig Dis Sci, 40 (1995), pp. 2550-2554
[5.]
JJGHM Bergman, E.A.J. Rauws, P. Fockens, A.M. Van Berkel, P.M.M. Bossuyt, J.G.P. Tijssen, et al.
Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bile duct stones.
Lancet, 349 (1997), pp. 1124-1129
[6.]
Y. Komatsu, T. Kawabe, N. Toda, M. Ohashi, M. Isayama, K. Tateishi, et al.
Endoscopic papillary balloon dilation for the management of common bile duct stones: experience of 226 cases.
Endoscopy, 30 (1998), pp. 12-17
[7.]
H. Sato, T. Kodama, J. Takaaki, Y. Tatsumi, T. Maeda, S. Fujita, et al.
Endoscopic papillary balloon dilation may preserve sphincter of Oddi function after common bile duct stone management: evaluation from the viewpoint of endoscopic manometry.
Gut, 41 (1997), pp. 541-544
[8.]
P. MacMathuna, D. Siegenberg, D. Gibbons, D. Gorin, M. O'Brien, N.A. Afdhal, et al.
The acute and long-term effect of balloon sphincteroplasty on papillary structure in pigs.
Gastrointest Endosc, 44 (1996), pp. 650-655
[9.]
R.A. Kozarek.
Hydrostatic balloon dilation of gastrointestinal stenoses: a national survey.
Gastrointest Endosc, 32 (1986), pp. 15-19
[10.]
N. Ueno, Y. Ozawa.
Pancreatitis induced by endoscopic balloon sphincter dilation and changes in serum amylase levels after the procedure.
Gastrointest Endosc, 49 (1999), pp. 472-476
[11.]
J.J. Bergman, A.M. van Berkel, M.J. Bruno, P. Fockens, E.A. Rauws, J.G. Tijssen, et al.
Is endoscopic balloon dilation for removal of bile duct stones associated with an increase risk for pancreatitis or a higher rate of hyperamylasemia?.
Endoscopy, 33 (2001), pp. 416-420
[12.]
J.C. Arnold, C. Benz, W.R. Martin, H.E. Adamek, J.F. Riemann.
Endoscopic papillary balloon dilation v.s.sphincterotomy for removal of common bile duct stones: a prospective randomized pilot study.
Endoscopy, 33 (2001), pp. 563-567
[13.]
P.B. Cotton, G. Lehman, J. Vennes, J.E. Geenen, R.C. Russell, W.C. Meyers, et al.
Endoscopic sphincterotomy complications and their management: an attempt at consensus.
Gastrointest Endosc, 37 (1991), pp. 383-393
[14.]
J.J. Bergman, K. Huibregtse.
What is the current status of endoscopic balloon dilation for stone removal?.
Endoscopy, 30 (1998), pp. 43-45
[15.]
J.J. Bergman, A.M. Van Berkel, M.J. Bruno, P. Fockens, E.A. Rauws, J.G. Tijssen, et al.
A randomized trial of endoscopic balloon dilation and endoscopic sphincterotomy for removal of bile duct stones in patients with a prior Billroth II gastrectomy.
Gastrointest Endosc, 53 (2001), pp. 19-26
[16.]
M. Staritz, K. Ewe, K.H. Meyer zum Buschenfelde.
Endoscopic papillary dilatation, a possible alternative to endoscopic papillotomy.
Lancet, 1 (1982), pp. 1306-1307
[17.]
M. Sugiyama, Y. Izumisato, N. Abe, T. Masaki, T. Mori, Y. Atomi.
Predictive factors for acute pancreatitis and hyperamylasemia after endoscopic papillary balloon dilation.
Gastrointest Endosc, 57 (2003), pp. 531-535
[18.]
J.A. Disario, M.L. Freeman, D.J. Bjorkman.
Endoscopic balloon dilation compared to sphincterotomy for extraction of bile duct stones [abstract].
Gastrointest Endosc, 45 (1999), pp. A129
[19.]
T. Aizawa, N. Ueno.
Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones.
Gastrointest Endosc, 54 (2001), pp. 209-213
[20.]
R.H. Kennedy, M.H. Thompson.
Are duodenal diverticula associated with choledocholithiasis?.
Gut, 29 (1988), pp. 1003-1006
[21.]
W. Kimura, H. Nagai, S. Kuroda, T. Muto.
No significant correlation between histologic changes of the papilla of Vater and juxtapapillary diverticulum. Special reference to the pathogenesis of gallstones.
Scand J Gastroenterol, 27 (1992), pp. 951-956
[22.]
A.P. Kirk, J.A. Summerfield.
Incidence and significance of juxtapapillary diverticula at endoscopic retrograde cholangio-pancreatography.
Digestion, 20 (1980), pp. 31-35
[23.]
M. Osnes, J. Myren, T. Lotveit, T. Svenson.
Juxtapapillary duodenal diverticula and abnormalities by endoscopic retrograde cholangiopancreatography (ERCP).
Scand J Gastroenterol, 12 (1977), pp. 347-351
[24.]
Y. Noda, N. Fujita, G. Kobayashi, K. Kimura, H. Watanabe, A. Chonan, et al.
Parapapillary duodenal diverticulum and endoscopic treatment.
Gastroenterol Digest, 5 (1993), pp. 1447-1454
[25.]
J.W. Leung, F.K. Chan, J.J. Sung, S.C. Chung.
Endoscopic sphincterotomy-induced hemorrhage: A study of risk factors and the role of epinephrine injection.
Gastrointest Endosc, 42 (1995), pp. 550-554
[26.]
J. Boender, G.A. Nix, M.A. de Ridder, M. Van Blankenstein, H.E. Schutte, J. Dees, et al.
Endoscopic papillotomy for common bile duct stones: Factors influencing the complication rate.
Endoscopy, 26 (1994), pp. 209-216
[27.]
M.L. Freeman, D.B. Nelson, S. Sherman, G.B. Haber, M.E. Herman, P.J. Dorsher, et al.
Complications of endoscopic biliary sphincterotomy.
N Engl J Med, 335 (1996), pp. 909-918
[28.]
R.W. Steiner, C. Coggins, A.C.A. Carvalho.
Bleeding time in uremia: a useful test to assess clinical bleeding.
Am J Hematol, 7 (1979), pp. 107-117
[29.]
D.B. Nelson, M.L. Freeman.
Major hemorrhage from endoscopic sphincterotomy: risk factor analysis.
J Clin Gastroenterol, 19 (1994), pp. 283-287
[30.]
Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures.
American Society for Gastrointestinal Endoscopy.
Gastrointest Endosc, 48 (1998), pp. 672-675
[31.]
M.H. Kim, S.K. Lee, M.H. Lee, S.J. Myung, B.M. Yoo, D.W. Seo, et al.
Endoscopic retrograde cholangiopancreatography in patients with Billroth II gastrectromy: a comparative study of the forward-viewing endoscope and the side-viewing duodenoscope.
Endoscopy, 29 (1997), pp. 82-85
[32.]
J.J. Bergman, A.M. Van Berkel, A.K. Groen, M.N. Schoeman, J. Offerhaus, G.N. Tytgat, et al.
Biliary manometry, bacterial characteristics, bile composition, and histologic changes fifteen to seventeen years after endoscopic sphincterotomy.
Gastrointest Endosc, 45 (1997), pp. 400-405
[33.]
J.J. Bergman, S. van der Mey, E.A. Rauws, J.G. Tijssen, D.J. Gouma, G.N. Tytgat, et al.
Long-term follow-up after endoscopic sphincterotomy for bile duct stones in patients younger than 60 years of age.
Gastrointest Endosc, 44 (1996), pp. 643-649
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos